Pralidoxime iodide - CAS 94-63-3

Name: Pralidoxime iodide
Brand: BOC Sciences
Rating: 5 (1 reviews)

Catalog:	BB041437
Product Name:	Pralidoxime iodide
CAS:	94-63-3
Synonyms:	2-PAM iodide; Protopam iodide; Pralidoxime methiodide

Technical Data

IUPAC Name:	(NE)-N-[(1-methylpyridin-1-ium-2-yl)methylidene]hydroxylamine;iodide
Description:	Pralidoxime iodide is an antidote, mainly used for pesticide poisoning.
Molecular Weight:	264.06
Molecular Formula:	C7H9IN2O
Canonical SMILES:	C[N+]1=CC=CC=C1C=NO.[I-]
InChI:	InChI=1S/C7H8N2O.HI/c1-9-5-3-2-4-7(9)6-8-10;/h2-6H,1H3;1H
InChI Key:	QNBVYCDYFJUNLO-UHFFFAOYSA-N
Melting Point:	220 °C (dec.)(lit.)
Density:	1.7439 g/cm³
Solubility:	>39.6 [ug/mL] (The mean of the results at pH 7.4)
Storage:	Store at 2-8 °C
LogP:	-2.67680
Stability:	No evidence of significant degradation products appears up to 48 hr after pralidoxime autoinjector discharge. Concentration without degradation of the solution was noted over time when the autoinjector needle caused coring of the vial closure ... Mark-1 autoinjectors are not suitable for administering pralidoxime to small children. However, The autoinjectors are a readily available source of concentrated pralidoxime for administering weight-adjusted doses in small children. The pralidoxime solution obtained in this manner remains chemically intact for at least 48 hr
Vapor Pressure:	6.74X10-4 mm Hg at 25 °C (est)

GHS Hazard Statement:	H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
Precautionary Statement:	P264, P270, P301+P312, P330, and P501
Signal Word:	Warning

Publication Number	Title	Priority Date
US-2020163952-A1	Compositions and methods for treating nerve agent exposure	20181126
WO-2020112766-A1	Compositions and methods for treating nerve agent exposure	20181126
WO-2020036231-A1	Drug management method for kit formulation requiring dose adjustment	20180817
EP-3838246-A1	Drug management method for kit formulation requiring dose adjustment	20180817
EP-3485265-A1	Method for electrochemical analysis by use of alternating output signals from two electrodes	20160712

PMID	Publication Date	Title	Journal
33592259	20210330	Reactivation of organophosphate-inhibited serum butyrylcholinesterase by novel substituted phenoxyalkyl pyridinium oximes and traditional oximes	Toxicology
32278739	20200601	Proline 285 is integral for the reactivation of organophosphate-inhibited human butyrylcholinesterase by 2-PAM	Chemico-biological interactions
31954867	20200515	Pharmacokinetics of Three Oximes in a Guinea Pig Model and Efficacy of Combined Oxime Therapy	Toxicology letters
31863869	20200315	Evaluation of high-affinity phenyltetrahydroisoquinoline aldoximes, linked through anti-triazoles, as reactivators of phosphylated cholinesterases	Toxicology letters
31276662	20190901	Reactivation potency of two novel oximes (K456 and K733) against paraoxon-inhibited acetyl and butyrylcholinesterase: In silico and in vitro models	Chemico-biological interactions

Complexity:	125
Compound Is Canonicalized:	Yes
Covalently-Bonded Unit Count:	2
Defined Atom Stereocenter Count:	0
Defined Bond Stereocenter Count:	1
Exact Mass:	263.97596
Formal Charge:	0
Heavy Atom Count:	11
Hydrogen Bond Acceptor Count:	3
Hydrogen Bond Donor Count:	1
Isotope Atom Count:	0
Monoisotopic Mass:	263.97596
Rotatable Bond Count:	1
Topological Polar Surface Area:	36.5 Å²
Undefined Atom Stereocenter Count:	0
Undefined Bond Stereocenter Count:	0